158 results on '"Mosqueda, J."'
Search Results
2. A new set of molecular markers for the genotyping of Babesia bovis isolates
- Author
-
Wilkowsky, S.E., Moretta, R., Mosqueda, J., Gil, G., Echaide, I., Lía, V., Falcón, A., Florin Christensen, M., and Farber, M.
- Published
- 2009
- Full Text
- View/download PDF
3. Evidence for Extensive Genetic Diversity and Substructuring of the Babesia bovis Metapopulation
- Author
-
Flores, D. A., Minichiello, Y., Araujo, F. R., Shkap, V., Benítez, D., Echaide, I., Rolls, P., Mosqueda, J., Pacheco, G. M., Petterson, M., Florin-Christensen, M., and Schnittger, L.
- Published
- 2013
- Full Text
- View/download PDF
4. The cost of illness of atrial fibrillation: a systematic review of the recent literature
- Author
-
Wolowacz, S.E., Samuel, M., Brennan, V.K., Jasso-Mosqueda, J.-G., and Van Gelder, I.C.
- Published
- 2011
- Full Text
- View/download PDF
5. Molecular Characterization of Babesia bovis Strains Using PCR Restriction Fragment Length Polymorphism Analysis of the msa2-a/b Genes
- Author
-
Wilkowsky, Silvina, Farber, M., Gil, G., Echaide, I., Mosqueda, J., Alcaraz, E., Suarez, C. E., and Florin-Christensen, M.
- Published
- 2008
- Full Text
- View/download PDF
6. Bovine Babesiosis and Anaplasmosis Follow-up on Cattle Relocated in an Endemic Area for Hemoparasitic Diseasesa
- Author
-
FIGUEROA, J. V., ALVAREZ, J. A., RAMOS, J. A., ROJAS, E. E., SANTIAGO, C., MOSQUEDA, J. J., VEGA, C. A., and BUENING, G. M.
- Published
- 1998
7. Major differences in organization and availability of health care and medicines for HIV/TB coinfected patients across Europe
- Author
-
Mansfeld M., Skrahina A., Shepherd L., Schultze A., Panteleev A., Miller R., Miro J., Zeltina I., Tetradov S., Furrer H., Kirk O., Grzeszczuk A., Bolokadze N., Matteelli A., Post F., Lundgren J., Mocroft A., Efsen A., Podlekareva D., Losso M. H., Toibaro J. J., Palmero D., Bartoletti B. J., E. Warley, Gear O., Messina O. G., Michans M., Laplume H., David D., Marson C., Scapelatto F. P., Dalessandro D., Lupo S., Costilla Campero G., Herbst M., Remondegui C., Elias C., Karpov I., Vassilenko A., Skrahina E., Skrahin A., Zalutskya A., Kondratenko O., Mitsura V., Bondarenko V., Suetnov O., Paduto D., Dewit S., Payen M. C., Noscoi C., Kabeya K., M. Wolff, Cortes C., Obel N., Kronborg G., Iljna V., Kummik T., Bryand M., Dabis F., Lanchava N., Bablishvili N., Goginashvili L., Mikiashvili L., Mshvidobadze K., Girardi E., Di Biagio A., Apostoli A., Barzoni S., Lapadula G., Purgatorio M., Carbonara S., Rozentale B., Janushkevich I., Caplinskas S., Kancauskienne Z., Caplinskienne I., Crabtree B., Pina A., Madero J. S., Mosqueda J., Villanueva J. A., Bura M., Garlicki A., Inglot M., Knysz B., Kozlowska J., Loster J., Mularska E., Podlasin R., Thompson M., Wiercinska-Drapalo A., Duiculescu D., Rakhmanova A., Yakovlev A., Turkalova A., Vlasova Y., Trotimora T., Borodulina E., Chumanova L., Mashkova Y., Miro J. M., Cayla J. A., Moreno A., Millet J. P., Orcau A., Fina L., del Bano L., Roldan L. L., Romero A., Martinez J. A., Manzardo C., Gonzalez J., Tudo G., Knobel H., Sanchez F., Salvado M., Curran A., Tortola M. T., Pozamczer D., Saumoy M., Alcaide F., Martinez-Lacasa X., Cuchi E., Sambeat M. A., Pomar V., Coll P., Miralles P., Moreno S., Iribarren J. A., Ibarguren M., Aldamiz T., Rickenbach M., Sagette M., Post F. A., Miller R. F., Chapman A., Dockrell D., Wilkins E., Cooke G., Ainsworth J., Macallen D., Dhar J., Vora N., Mullaney S., Kegg S., Kyselyova G., Mansfeld, M, Skrahina, A, Shepherd, L, Schultze, A, Panteleev, A, Miller, R, Miro, J, Zeltina, I, Tetradov, S, Furrer, H, Kirk, O, Grzeszczuk, A, Bolokadze, N, Matteelli, A, Post, F, Lundgren, J, Mocroft, A, Efsen, A, Podlekareva, D, Losso, M, Toibaro, J, Palmero, D, Bartoletti, B, E., W, Gear, O, Messina, O, Michans, M, Laplume, H, David, D, Marson, C, Scapelatto, F, Dalessandro, D, Lupo, S, Costilla Campero, G, Herbst, M, Remondegui, C, Elias, C, Karpov, I, Vassilenko, A, Skrahina, E, Skrahin, A, Zalutskya, A, Kondratenko, O, Mitsura, V, Bondarenko, V, Suetnov, O, Paduto, D, Dewit, S, Payen, M, Noscoi, C, Kabeya, K, M., W, Cortes, C, Obel, N, Kronborg, G, Iljna, V, Kummik, T, Bryand, M, Dabis, F, Lanchava, N, Bablishvili, N, Goginashvili, L, Mikiashvili, L, Mshvidobadze, K, Girardi, E, Di Biagio, A, Apostoli, A, Barzoni, S, Lapadula, G, Purgatorio, M, Carbonara, S, Rozentale, B, Janushkevich, I, Caplinskas, S, Kancauskienne, Z, Caplinskienne, I, Crabtree, B, Pina, A, Madero, J, Mosqueda, J, Villanueva, J, Bura, M, Garlicki, A, Inglot, M, Knysz, B, Kozlowska, J, Loster, J, Mularska, E, Podlasin, R, Thompson, M, Wiercinska-Drapalo, A, Duiculescu, D, Rakhmanova, A, Yakovlev, A, Turkalova, A, Vlasova, Y, Trotimora, T, Borodulina, E, Chumanova, L, Mashkova, Y, Cayla, J, Moreno, A, Millet, J, Orcau, A, Fina, L, del Bano, L, Roldan, L, Romero, A, Martinez, J, Manzardo, C, Gonzalez, J, Tudo, G, Knobel, H, Sanchez, F, Salvado, M, Curran, A, Tortola, M, Pozamczer, D, Saumoy, M, Alcaide, F, Martinez-Lacasa, X, Cuchi, E, Sambeat, M, Pomar, V, Coll, P, Miralles, P, Moreno, S, Iribarren, J, Ibarguren, M, Aldamiz, T, Rickenbach, M, Sagette, M, Chapman, A, Dockrell, D, Wilkins, E, Cooke, G, Ainsworth, J, Macallen, D, Dhar, J, Vora, N, Mullaney, S, Kegg, S, and Kyselyova, G
- Subjects
Tuberculosi ,Coinfection ,Health Policy ,Antitubercular Agents ,HIV ,1103 Clinical Sciences ,HIV Infections ,Eastern ,Health Surveys ,Article ,Europe ,Infectious Diseases ,Cross-Sectional Studies ,Rifabutin ,Delivery of health care ,Integrated ,Tuberculosis ,Europe, Eastern ,Humans ,Opiate Substitution Treatment ,Pharmacology (medical) ,Virology ,610 Medicine & health - Abstract
Objectives: The aim of the study was to investigate the organization and delivery of HIV and tuberculosis (TB) health care and to analyse potential differences between treatment centres in Eastern (EE) and Western Europe (WE). Methods: Thirty-eight European HIV and TB treatment centres participating in the TB:HIV study within EuroCoord completed a survey on health care management for coinfected patients in 2013 (EE: 17 respondents; WE:21; 76% of all TB:HIV centres). Descriptive statistics were obtained for regional comparisons. The reported data on health care strategies were compared with actual clinical practice at patient level via data derived from the TB:HIV study. Results: Respondent centres in EE comprised: Belarus (n=3), Estonia (1), Georgia (1), Latvia (1), Lithuania (1), Poland (4), Romania (1), the Russian Federation (4) and Ukraine (1); those in WE comprised: Belgium (1), Denmark (1), France (1), Italy (7), Spain (2), Switzerland (1) and UK (8). Compared with WE, treatment of HIV and TB in EE are less often located at the same site (47% in EE versus 100% in WE; P
- Published
- 2015
8. Major differences in organization and availability of health care and medicines for HIV/TB coinfected patients across Europe
- Author
-
Mansfeld, M, Skrahina, A, Shepherd, L, Schultze, A, Panteleev, A, Miller, R, Miro, J, Zeltina, I, Tetradov, S, Furrer, H, Kirk, O, Grzeszczuk, A, Bolokadze, N, Matteelli, A, Post, F, Lundgren, J, Mocroft, A, Efsen, A, Podlekareva, D, Losso, M, Toibaro, J, Palmero, D, Bartoletti, B, E., W, Gear, O, Messina, O, Michans, M, Laplume, H, David, D, Marson, C, Scapelatto, F, Dalessandro, D, Lupo, S, Costilla Campero, G, Herbst, M, Remondegui, C, Elias, C, Karpov, I, Vassilenko, A, Skrahina, E, Skrahin, A, Zalutskya, A, Kondratenko, O, Mitsura, V, Bondarenko, V, Suetnov, O, Paduto, D, Dewit, S, Payen, M, Noscoi, C, Kabeya, K, M., W, Cortes, C, Obel, N, Kronborg, G, Iljna, V, Kummik, T, Bryand, M, Dabis, F, Lanchava, N, Bablishvili, N, Goginashvili, L, Mikiashvili, L, Mshvidobadze, K, Girardi, E, Di Biagio, A, Apostoli, A, Barzoni, S, Lapadula, G, Purgatorio, M, Carbonara, S, Rozentale, B, Janushkevich, I, Caplinskas, S, Kancauskienne, Z, Caplinskienne, I, Crabtree, B, Pina, A, Madero, J, Mosqueda, J, Villanueva, J, Bura, M, Garlicki, A, Inglot, M, Knysz, B, Kozlowska, J, Loster, J, Mularska, E, Podlasin, R, Thompson, M, Wiercinska-Drapalo, A, Duiculescu, D, Rakhmanova, A, Yakovlev, A, Turkalova, A, Vlasova, Y, Trotimora, T, Borodulina, E, Chumanova, L, Mashkova, Y, Cayla, J, Moreno, A, Millet, J, Orcau, A, Fina, L, del Bano, L, Roldan, L, Romero, A, Martinez, J, Manzardo, C, Gonzalez, J, Tudo, G, Knobel, H, Sanchez, F, Salvado, M, Curran, A, Tortola, M, Pozamczer, D, Saumoy, M, Alcaide, F, Martinez-Lacasa, X, Cuchi, E, Sambeat, M, Pomar, V, Coll, P, Miralles, P, Moreno, S, Iribarren, J, Ibarguren, M, Aldamiz, T, Rickenbach, M, Sagette, M, Chapman, A, Dockrell, D, Wilkins, E, Cooke, G, Ainsworth, J, Macallen, D, Dhar, J, Vora, N, Mullaney, S, Kegg, S, Kyselyova, G, Mansfeld M., Skrahina A., Shepherd L., Schultze A., Panteleev A., Miller R., Miro J., Zeltina I., Tetradov S., Furrer H., Kirk O., Grzeszczuk A., Bolokadze N., Matteelli A., Post F., Lundgren J., Mocroft A., Efsen A., Podlekareva D., Losso M. H., Toibaro J. J., Palmero D., Bartoletti B. J., E. Warley, Gear O., Messina O. G., Michans M., Laplume H., David D., Marson C., Scapelatto F. P., Dalessandro D., Lupo S., Costilla Campero G., Herbst M., Remondegui C., Elias C., Karpov I., Vassilenko A., Skrahina E., Skrahin A., Zalutskya A., Kondratenko O., Mitsura V., Bondarenko V., Suetnov O., Paduto D., Dewit S., Payen M. C., Noscoi C., Kabeya K., M. Wolff, Cortes C., Obel N., Kronborg G., Iljna V., Kummik T., Bryand M., Dabis F., Lanchava N., Bablishvili N., Goginashvili L., Mikiashvili L., Mshvidobadze K., Girardi E., Di Biagio A., Apostoli A., Barzoni S., Lapadula G., Purgatorio M., Carbonara S., Rozentale B., Janushkevich I., Caplinskas S., Kancauskienne Z., Caplinskienne I., Crabtree B., Pina A., Madero J. S., Mosqueda J., Villanueva J. A., Bura M., Garlicki A., Inglot M., Knysz B., Kozlowska J., Loster J., Mularska E., Podlasin R., Thompson M., Wiercinska-Drapalo A., Duiculescu D., Rakhmanova A., Yakovlev A., Turkalova A., Vlasova Y., Trotimora T., Borodulina E., Chumanova L., Mashkova Y., Miro J. M., Cayla J. A., Moreno A., Millet J. P., Orcau A., Fina L., del Bano L., Roldan L. L., Romero A., Martinez J. A., Manzardo C., Gonzalez J., Tudo G., Knobel H., Sanchez F., Salvado M., Curran A., Tortola M. T., Pozamczer D., Saumoy M., Alcaide F., Martinez-Lacasa X., Cuchi E., Sambeat M. A., Pomar V., Coll P., Miralles P., Moreno S., Iribarren J. A., Ibarguren M., Aldamiz T., Rickenbach M., Sagette M., Post F. A., Miller R. F., Chapman A., Dockrell D., Wilkins E., Cooke G., Ainsworth J., Macallen D., Dhar J., Vora N., Mullaney S., Kegg S., Kyselyova G., Mansfeld, M, Skrahina, A, Shepherd, L, Schultze, A, Panteleev, A, Miller, R, Miro, J, Zeltina, I, Tetradov, S, Furrer, H, Kirk, O, Grzeszczuk, A, Bolokadze, N, Matteelli, A, Post, F, Lundgren, J, Mocroft, A, Efsen, A, Podlekareva, D, Losso, M, Toibaro, J, Palmero, D, Bartoletti, B, E., W, Gear, O, Messina, O, Michans, M, Laplume, H, David, D, Marson, C, Scapelatto, F, Dalessandro, D, Lupo, S, Costilla Campero, G, Herbst, M, Remondegui, C, Elias, C, Karpov, I, Vassilenko, A, Skrahina, E, Skrahin, A, Zalutskya, A, Kondratenko, O, Mitsura, V, Bondarenko, V, Suetnov, O, Paduto, D, Dewit, S, Payen, M, Noscoi, C, Kabeya, K, M., W, Cortes, C, Obel, N, Kronborg, G, Iljna, V, Kummik, T, Bryand, M, Dabis, F, Lanchava, N, Bablishvili, N, Goginashvili, L, Mikiashvili, L, Mshvidobadze, K, Girardi, E, Di Biagio, A, Apostoli, A, Barzoni, S, Lapadula, G, Purgatorio, M, Carbonara, S, Rozentale, B, Janushkevich, I, Caplinskas, S, Kancauskienne, Z, Caplinskienne, I, Crabtree, B, Pina, A, Madero, J, Mosqueda, J, Villanueva, J, Bura, M, Garlicki, A, Inglot, M, Knysz, B, Kozlowska, J, Loster, J, Mularska, E, Podlasin, R, Thompson, M, Wiercinska-Drapalo, A, Duiculescu, D, Rakhmanova, A, Yakovlev, A, Turkalova, A, Vlasova, Y, Trotimora, T, Borodulina, E, Chumanova, L, Mashkova, Y, Cayla, J, Moreno, A, Millet, J, Orcau, A, Fina, L, del Bano, L, Roldan, L, Romero, A, Martinez, J, Manzardo, C, Gonzalez, J, Tudo, G, Knobel, H, Sanchez, F, Salvado, M, Curran, A, Tortola, M, Pozamczer, D, Saumoy, M, Alcaide, F, Martinez-Lacasa, X, Cuchi, E, Sambeat, M, Pomar, V, Coll, P, Miralles, P, Moreno, S, Iribarren, J, Ibarguren, M, Aldamiz, T, Rickenbach, M, Sagette, M, Chapman, A, Dockrell, D, Wilkins, E, Cooke, G, Ainsworth, J, Macallen, D, Dhar, J, Vora, N, Mullaney, S, Kegg, S, Kyselyova, G, Mansfeld M., Skrahina A., Shepherd L., Schultze A., Panteleev A., Miller R., Miro J., Zeltina I., Tetradov S., Furrer H., Kirk O., Grzeszczuk A., Bolokadze N., Matteelli A., Post F., Lundgren J., Mocroft A., Efsen A., Podlekareva D., Losso M. H., Toibaro J. J., Palmero D., Bartoletti B. J., E. Warley, Gear O., Messina O. G., Michans M., Laplume H., David D., Marson C., Scapelatto F. P., Dalessandro D., Lupo S., Costilla Campero G., Herbst M., Remondegui C., Elias C., Karpov I., Vassilenko A., Skrahina E., Skrahin A., Zalutskya A., Kondratenko O., Mitsura V., Bondarenko V., Suetnov O., Paduto D., Dewit S., Payen M. C., Noscoi C., Kabeya K., M. Wolff, Cortes C., Obel N., Kronborg G., Iljna V., Kummik T., Bryand M., Dabis F., Lanchava N., Bablishvili N., Goginashvili L., Mikiashvili L., Mshvidobadze K., Girardi E., Di Biagio A., Apostoli A., Barzoni S., Lapadula G., Purgatorio M., Carbonara S., Rozentale B., Janushkevich I., Caplinskas S., Kancauskienne Z., Caplinskienne I., Crabtree B., Pina A., Madero J. S., Mosqueda J., Villanueva J. A., Bura M., Garlicki A., Inglot M., Knysz B., Kozlowska J., Loster J., Mularska E., Podlasin R., Thompson M., Wiercinska-Drapalo A., Duiculescu D., Rakhmanova A., Yakovlev A., Turkalova A., Vlasova Y., Trotimora T., Borodulina E., Chumanova L., Mashkova Y., Miro J. M., Cayla J. A., Moreno A., Millet J. P., Orcau A., Fina L., del Bano L., Roldan L. L., Romero A., Martinez J. A., Manzardo C., Gonzalez J., Tudo G., Knobel H., Sanchez F., Salvado M., Curran A., Tortola M. T., Pozamczer D., Saumoy M., Alcaide F., Martinez-Lacasa X., Cuchi E., Sambeat M. A., Pomar V., Coll P., Miralles P., Moreno S., Iribarren J. A., Ibarguren M., Aldamiz T., Rickenbach M., Sagette M., Post F. A., Miller R. F., Chapman A., Dockrell D., Wilkins E., Cooke G., Ainsworth J., Macallen D., Dhar J., Vora N., Mullaney S., Kegg S., and Kyselyova G.
- Abstract
Objectives: The aim of the study was to investigate the organization and delivery of HIV and tuberculosis (TB) health care and to analyse potential differences between treatment centres in Eastern (EE) and Western Europe (WE). Methods: Thirty-eight European HIV and TB treatment centres participating in the TB:HIV study within EuroCoord completed a survey on health care management for coinfected patients in 2013 (EE: 17 respondents; WE:21; 76% of all TB:HIV centres). Descriptive statistics were obtained for regional comparisons. The reported data on health care strategies were compared with actual clinical practice at patient level via data derived from the TB:HIV study. Results: Respondent centres in EE comprised: Belarus (n=3), Estonia (1), Georgia (1), Latvia (1), Lithuania (1), Poland (4), Romania (1), the Russian Federation (4) and Ukraine (1); those in WE comprised: Belgium (1), Denmark (1), France (1), Italy (7), Spain (2), Switzerland (1) and UK (8). Compared with WE, treatment of HIV and TB in EE are less often located at the same site (47% in EE versus 100% in WE; P<0.001) and less often provided by the same doctors (41% versus 90%, respectively; P=0.002), whereas regular screening of HIV-infected patients for TB (80% versus 40%, respectively; P=0.037) and directly observed treatment (88% versus 20%, respectively; P<0.001) were more common in EE. The reported availability of rifabutin and second- and third-line anti-TB drugs was lower, and opioid substitution therapy (OST) was available at fewer centres in EE compared with WE (53% versus 100%, respectively; P<0.001). Conclusions: Major differences exist between EE and WE in relation to the organization and delivery of health care for HIV/TB-coinfected patients and the availability of anti-TB drugs and OST. Significant discrepancies between reported and actual clinical practices were found in EE.
- Published
- 2015
9. Identification and molecular characterization of an antigen of Babesia bigemina with homology to the Apical Membrane Antigen 1 (AMA-1) of Apicomplexa
- Author
-
Mosqueda, J., Ramos, J., Falcon, A., Torna, A., Figueroa, J., Alvarez, A., Bautista, R., Cantò, G., Agnone, A., Mosqueda, J, Ramos, J, Falcon, A, Torna, A, Figueroa, J, Alvarez, A, Bautista, R, Cantò, G, and Agnone, A.
- Subjects
Babesia bigemina, AMA-1 - Published
- 2008
10. Characterization of a novel Babesia bigemina gene and its potential use as molecular marker for strain discrimination
- Author
-
Mosqueda, J, Vichido, R, Ramos, J, Falcòn, A, Torina, A, Petrig, R, Farber, M, Araujo, F, Ica, A, Camacho Nuez, M, Alvarez, A, Camacho, E., AGNONE, Annalisa, Mosqueda, J, Vichido, R, Ramos, J, Falcòn, A, Agnone, A, Torina, A, Petrig, R, Farber, M, Araujo, F, Ica, A, Camacho Nuez, M, Alvarez, A, and Camacho, E
- Subjects
Babesia bigemina, strain discrimination - Published
- 2008
11. Sequence variability in the Babesia bigemina merozoite surface antigen GP45 gene among Mexican and Italian isolates
- Author
-
AGNONE, Annalisa, Mosqueda, J, Vichido, R, Torina, A., Agnone, A, Mosqueda, J, Vichido, R, and Torina, A
- Subjects
Babesia bigemina, merozoite surface Antigen gp45 - Published
- 2008
12. Cattle tick vaccine researchers join forces in CATVAC
- Author
-
Schetters, T., Bishop, R., Crampton, M., Kopáček, P., Lew-Tabor, A., Maritz-Olivier, C., Miller, R., Mosqueda, J., Patarroyo, J., Rodriguez-Valle, M., Scoles, G.A., de la Fuente, J., Schetters, T., Bishop, R., Crampton, M., Kopáček, P., Lew-Tabor, A., Maritz-Olivier, C., Miller, R., Mosqueda, J., Patarroyo, J., Rodriguez-Valle, M., Scoles, G.A., and de la Fuente, J.
- Abstract
A meeting sponsored by the Bill & Melinda Gates Foundation was held at the Avanti Hotel, Mohammedia, Morocco, July 14–15, 2015. The meeting resulted in the formation of the Cattle Tick Vaccine Consortium (CATVAC).
- Published
- 2016
13. Juicio de expertos para la validación de un instrumento de medición del síndrome de burnout en la docencia
- Author
-
Dorantes Nova, Judith A., primary, Hernández Mosqueda, J. Silvano, additional, and Tobón Tobón, Sergio, additional
- Published
- 2016
- Full Text
- View/download PDF
14. A Systematic Literature Review to Identify Clinical Drivers in Cost-Effectiveness Analyses in T2DM Patients Uncontrolled on Current Therapies
- Author
-
Afonso, M, primary, Gupta, J, additional, Kamra, S, additional, and Jasso-Mosqueda, J, additional
- Published
- 2016
- Full Text
- View/download PDF
15. AB0936 Tuberculosis Infection in Mexican Patients with Idiopathic Inflammatory Myopathies: Report of three Cases and Review of the Literature
- Author
-
Pérez Cruz, P.J., primary, Gόmez-Bañuelos, E., additional, Aguilar-Arreola, J.E., additional, Saldaña Millán, A., additional, Andrade-Ortega, L., additional, Jara-Quezada, L.J., additional, Saavedra, M.A., additional, Vera-Lastra, O., additional, Medrano-Ramírez, G., additional, Pizano-Martínez, O., additional, Martín-Márquez, B.T., additional, Navarro-Hernandez, R.E., additional, Floresvillar-Mosqueda, J., additional, and Vazquez-Del Mercado, M., additional
- Published
- 2015
- Full Text
- View/download PDF
16. Caratterizzazione dell'antigene AMA1 in ceppi di Babesia bigemina isolati in Italia
- Author
-
Torina, A, Mosqueda, J. J., Cerrone, A, Cusumano, F, Stancanelli, A, Caracappa, S., AGNONE, Annalisa, SIRECI, Guido, BLANDA, Valeria, ALBANESE, Ida, LA FARINA, Mario, Torina, A, Agnone, A, Sireci, G, Mosqueda, J.J., Blanda, V, Albanese, I, La Farina, M, Cerrone, A, Cusumano, F, Stancanelli, A, and Caracappa, S
- Subjects
B.bigemina ,AMA-1 ,Vaccine - Abstract
Babesia bigemina is an endemic parasite in different parts of the world, including Europe and the Americas. One of the few genes characterized in this species codifies for the apical membrane antigen 1 (AMA-1), a transmembrane antigen recently identified. We characterized the ama-1 gene from three Italian B. bigemina strains. Italian sequences were compared to those of the Australian strain. The results obtained confirmed that this newly described ama-1 gene is highly conserved among Italian and foreign strains, which has implications for vaccine development.
- Published
- 2009
17. Türkiye'nin Çeşitli Yörelerinden Elde Edilen Babesia bovis ve Babesia bigemina'nın Moleküler Karakterizasyonu
- Author
-
Mosqueda, J, Florin-Christensen, M, Yıldırım, Alparslan, Düzlü, Önder, Vatansever, Zehra, İça, Anıl, İnci, Abdullah, and Yavuz, A
- Published
- 2007
18. PDB53 - A Systematic Literature Review to Identify Clinical Drivers in Cost-Effectiveness Analyses in T2DM Patients Uncontrolled on Current Therapies
- Author
-
Afonso, M, Gupta, J, Kamra, S, and Jasso-Mosqueda, J
- Published
- 2016
- Full Text
- View/download PDF
19. Validation of a Competitive Enzyme-Linked Immunosorbent Assay for Detection of Babesia bigemina Antibodies in Cattle
- Author
-
Goff, W.L., Johnson, W.C., Molloy, J.B., Jorgensen, W.K., Waldron, S.J., Figueroa, J.V., Matthee, O., Adams, D.S., McGuire, T.C., Pino, I., Mosqueda, J., Palmer, G.H., Suarez, C.E., Knowles, D.P., McElwain, T.F., Goff, W.L., Johnson, W.C., Molloy, J.B., Jorgensen, W.K., Waldron, S.J., Figueroa, J.V., Matthee, O., Adams, D.S., McGuire, T.C., Pino, I., Mosqueda, J., Palmer, G.H., Suarez, C.E., Knowles, D.P., and McElwain, T.F.
- Abstract
A competitive enzyme-linked immunosorbent assay (cELISA) based on a broadly conserved, species-specific, B-cell epitope within the C terminus of Babesia bigemina rhoptry-associated protein 1a was validated for international use. Receiver operating characteristic analysis revealed 16% inhibition as the threshold for a negative result, with an associated specificity of 98.3% and sensitivity of 94.7%. Increasing the threshold to 21% increased the specificity to 100% but modestly decreased the sensitivity to 87.2%. By using 21% inhibition, the positive predictive values ranged from 90.7% (10% prevalence) to 100% (95% prevalence) and the negative predictive values ranged from 97.0% (10% prevalence) to 48.2% (95% prevalence). The assay was able to detect serum antibody as early as 7 days after intravenous inoculation. The cELISA was distributed to five different laboratories along with a reference set of 100 defined bovine serum samples, including known positive, known negative, and field samples. The pairwise concordance among the five laboratories ranged from 100% to 97%, and all kappa values were above 0.8, indicating a high degree of reliability. Overall, the cELISA appears to have the attributes necessary for international application.
- Published
- 2008
20. Overall Survival in Metastatic Colorectal Cancer (MCRC) Patients Receiving 2nd-Line therapy: A Systematic Review
- Author
-
Martin, A.L., primary, Xu, Y., additional, Knopf, K., additional, Iqbal, S.U., additional, and Jasso-Mosqueda, J., additional
- Published
- 2012
- Full Text
- View/download PDF
21. The prevalence and abundance of helminth parasites in stray dogs from the city of Queretaro in central Mexico
- Author
-
Cantó, G.J., primary, García, M.P., additional, García, A., additional, Guerrero, M.J., additional, and Mosqueda, J., additional
- Published
- 2010
- Full Text
- View/download PDF
22. Characterization of the Apical Membrane Antigen-1 in Italian Strains of Babesia bigemina
- Author
-
Torina, A., primary, Agnone, A., additional, Sireci, G., additional, Mosqueda, J. J., additional, Blanda, V., additional, Albanese, I., additional, La Farina, M., additional, Cerrone, A., additional, Cusumano, F., additional, and Caracappa, S., additional
- Published
- 2010
- Full Text
- View/download PDF
23. Molecular Characterization ofBabesia bovisStrains Using PCR Restriction Fragment Length Polymorphism Analysis of themsa2-a/bGenes
- Author
-
Wilkowsky, Silvina, primary, Farber, M., additional, Gil, G., additional, Echaide, I., additional, Mosqueda, J., additional, Alcaraz, E., additional, Suarez, C. E., additional, and Florin-Christensen, M., additional
- Published
- 2008
- Full Text
- View/download PDF
24. PHP45 APPRAISAL OF FIVE NEW OUT-OF-HOURS (OOH) PRIMARY CARE CENTRES IN THE PARISIAN REGION: “MAISONS MÉDICALES DE GARDE (MMG)”
- Author
-
Lemasson, H, primary, Jasso Mosqueda, J, additional, and Chicoye, A, additional
- Published
- 2005
- Full Text
- View/download PDF
25. The treatment of mice with Lactobacillus casei induces protection against Babesia microti infection
- Author
-
Bautista-Garfias, C.R., primary, Gómez, M.B., additional, Aguilar, B.R., additional, Ixta, O., additional, Martínez, F., additional, and Mosqueda, J., additional
- Published
- 2005
- Full Text
- View/download PDF
26. Comparative Sensitivity of Two Tests for the Diagnosis of Multiple Hemoparasite Infection of Cattlea
- Author
-
FIGUEROA, J. V., primary, ALVAREZ, J. A., additional, CANTO, G. J., additional, RAMOS, J. A., additional, MOSQUEDA, J. J., additional, and BUENING, G. M., additional
- Published
- 1996
- Full Text
- View/download PDF
27. 597P - Overall Survival in Metastatic Colorectal Cancer (MCRC) Patients Receiving 2nd-Line therapy: A Systematic Review
- Author
-
Martin, A.L., Xu, Y., Knopf, K., Iqbal, S.U., and Jasso-Mosqueda, J.
- Published
- 2012
- Full Text
- View/download PDF
28. Current Advances in Detection and Treatment of Babesiosis
- Author
-
Mosqueda, J., Olvera-Ramirez, A., Aguilar-Tipacamu, G., and J. Canto, G.
- Abstract
Babesiosis is a disease with a world-wide distribution affecting many species of mammals principally cattle and man. The major impact occurs in the cattle industry where bovine babesiosis has had a huge economic effect due to loss of meat and beef production of infected animals and death. Nowadays to those costs there must be added the high cost of tick control, disease detection, prevention and treatment. In almost a century and a quarter since the first report of the disease, the truth is: there is no a safe and efficient vaccine available, there are limited chemotherapeutic choices and few low-cost, reliable and fast detection methods. Detection and treatment of babesiosis are important tools to control babesiosis. Microscopy detection methods are still the cheapest and fastest methods used to identify Babesia parasites although their sensitivity and specificity are limited. Newer immunological methods are being developed and they offer faster, more sensitive and more specific options to conventional methods, although the direct immunological diagnoses of parasite antigens in host tissues are still missing. Detection methods based on nucleic acid identification and their amplification are the most sensitive and reliable techniques available today; importantly, most of those methodologies were developed before the genomics and bioinformatics era, which leaves ample room for optimization. For years, babesiosis treatment has been based on the use of very few drugs like imidocarb or diminazene aceturate. Recently, several pharmacological compounds were developed and evaluated, offering new options to control the disease. With the complete sequence of the Babesia bovis genome and the B. bigemina genome project in progress, the post-genomic era brings a new light on the development of diagnosis methods and new chemotherapy targets. In this review, we will present the current advances in detection and treatment of babesiosis in cattle and other animals, with additional reference to several apicomplexan parasites.
- Published
- 2012
29. Bovine Babesiosis and Anaplasmosis Follow-up on Cattle Relocated in an Endemic Area for Hemoparasitic Diseasesa.
- Author
-
FIGUEROA, J. V., ALVAREZ, J. A., RAMOS, J. A., ROJAS, E. E., SANTIAGO, C., MOSQUEDA, J. J., VEGA, C. A., and BUENING, G. M.
- Published
- 1998
- Full Text
- View/download PDF
30. Characterization of the Apical Membrane Antigen-1 in Italian Strains of Babesia bigemina
- Author
-
Torina, A., Agnone, A., Sireci, G., Mosqueda, J. J., Blanda, V., Albanese, I., La Farina, M., Cerrone, A., Cusumano, F., and Caracappa, S.
- Abstract
Babesia bigeminais a parasite endemic in different parts of the world, including Europe and the Americas. One of the few genes characterized in this species codifies for the Apical Membrane Antigen 1 (AMA-1), a trans-membrane antigen recently identified. In this research, we characterized the ama-1gene from three Italian B. bigeminastrains, two B. bigeminastrains obtained from Ragusa, Sicily (ITA1 and ITA3) and a third one obtained from Benevento, Campania (ITA2). Italian sequences were compared with those of the Australian strain obtained from the Sanger Institute web site and to strains from different parts of the world. The results obtained confirmed that this newly described ama-1gene is highly conserved among Italian and foreign strains which has implications for vaccine development.
- Published
- 2010
- Full Text
- View/download PDF
31. In silico prediction of the CHH / ITP neuropeptide in R. sanguineus, as a study model.
- Author
-
Tavares Espinosa, A. K., Mosqueda, J. J., Aguilar Tipacamú, G., and Gamez, B. I.Carvajal
- Subjects
BROWN dog tick ,NEUROPEPTIDES ,ENERGY metabolism - Abstract
R. sanguineus is one of the most important vectors of worldwide distribution, causing important diseases that affect the nervous system in humans by zoonoses. (1). The singanglion of ticks has not been fully explored (2), in this study we are interested in knowing if there is the presence of the CHH peptide which are documented and have a central role in the homeostatic regulation of energy metabolism, molting, reproduction and stress responses (3), so in future experimental studies it could be a therapeutic target. The objective is identify the CHH / ITP neuropeptide with in silico analysis for future experimental applications in the R. sanguineus tick. The Hypothesis is the neuropeptide CHH / ITP is conserved in the R. sanguineus tick. The study carried out by Andrew , 2008, showing transcripts encoding putative ipodoid neuropeptide precursors was taken as a reference, a phylogenetic tree was performed, a BLAST of the reference sequence was performed, online programs were used to identify the signal peptide, possible glycosylation sites as well as determine the possible secondary structure of the peptide.. Both insects such as crustaceans and ticks belong to the same edge so that this possibility is increased if this peptide is conserved, no glycosylated sites were analyzed and the prediction of its secondary structure showed an alpha helix with a turn and 1 beta sheet. [ABSTRACT FROM AUTHOR]
- Published
- 2019
32. Methicillin-resistant Staphylococcus aureus at a general hospital: Epidemiological overview between 2000-2007,Staphylococcus aureus resistente a meticilina en un hospital general: Panorama epidemiológico del 2000 al 2007
- Author
-
Álvarez-Canales, J. A., Ramirez, A. J., Mojica-Larrea, M., Huerta, J. D. R., Guerrero, J. D., Rolón, A. L., Medina, H., Muñoz, J. M., Mosqueda, J. L., Macías, A. E., and José Sifuentes-Osornio
33. Validity and reliability of a rubric for high school teachers' pedagogical practices assessment (SOCME-10),Validez y confiabilidad de una rúbrica para evaluar las prácticas pedagógicas en docentes de Educación Media (SOCME-10)
- Author
-
Tobón, S., Pimienta-Prieto, J. H., Sergio Raúl Herrera Meza, Juárezhernández, L. G., and Hernández-Mosqueda, J. S.
34. Teaching practice mediated by ICT: A significance construction,La práctica docente mediada por TIC: Una construcción de significados
- Author
-
Núñez, C., Gaviria Serrano, J. M., Tobón, S., Dino-Morales, L. I., Guzmán-Calderón, C. E., and Hernández-Mosqueda, J. S.
35. An Evaluation of the Cellular and Humoral Response of a Multi-Epitope Vaccine Candidate Against COVID-19 with Different Alum Adjuvants.
- Author
-
Vega Rojas LJ, Ruíz-Manzano RA, Velasco-Elizondo MA, Carbajo-Mata MA, Hernández-Silva DJ, Rocha-Solache M, Hernández J, Pérez-Serrano RM, Zaldívar-Lelo de Larrea G, García-Gasca T, and Mosqueda J
- Subjects
- Animals, Mice, Antibodies, Neutralizing blood, Antibodies, Neutralizing immunology, Female, Epitopes, T-Lymphocyte immunology, Immunity, Cellular drug effects, Immunity, Cellular immunology, Mice, Inbred BALB C, Adjuvants, Vaccine pharmacology, Epitopes, B-Lymphocyte immunology, Humans, Immunoglobulin G blood, Immunoglobulin G immunology, CD8-Positive T-Lymphocytes immunology, Cytokines metabolism, Spike Glycoprotein, Coronavirus immunology, COVID-19 Vaccines immunology, COVID-19 prevention & control, COVID-19 immunology, SARS-CoV-2 immunology, Alum Compounds pharmacology, Alum Compounds administration & dosage, Adjuvants, Immunologic pharmacology, Adjuvants, Immunologic administration & dosage, Antibodies, Viral blood, Antibodies, Viral immunology, Immunity, Humoral drug effects, Immunity, Humoral immunology
- Abstract
SARS-CoV-2 ( Betacoronavirus pandemicum ) is responsible for the disease identified by the World Health Organization (WHO) as COVID-19. We designed "CHIVAX 2.1", a multi-epitope vaccine, containing ten immunogenic peptides with conserved B-cell and T-cell epitopes in the receceptor binding domain (RBD) sequences of different SARS-CoV-2 variants of concern (VoCs). We evaluated the immune response of mice immunized with 20 or 60 µg of the chimeric protein with two different alum adjuvants (Alhydrogel
® and Adju-Phos® ), plus PHAD® , in a two-immunization regimen (0 and 21 days). Serum samples were collected on days 0, 21, 31, and 72 post first immunization, with antibody titers determined by indirect ELISA, while lymphoproliferation assays and cytokine production were evaluated by flow cytometry. The presence of neutralizing antibodies was assessed by surrogate neutralization assays. Higher titers of total IgG, IgG1 , and IgG2a antibodies, as well as increased proliferation rates of specific CD4+ and CD8+ T cells, were observed in mice immunized with 60 μg of protein plus Adju-Phos® /PHAD® . This formulation also generated the highest levels of TNF-α and IFN-γ, in addition to the presence of neutralizing antibodies against Delta and Omicron VoC. These findings indicate the potential of this chimeric multi-epitope vaccine with combined adjuvants as a promising platform against viral infections, eliciting a TH1 or TH1 :TH2 balanced cell response.- Published
- 2024
- Full Text
- View/download PDF
36. Loop-Mediated Isothermal Amplification Coupled with Reverse Line Blot Hybridization for the Detection of Pseudomonas aeruginosa .
- Author
-
Ferrusca Bernal D, Mosqueda J, Pérez-Sánchez G, Chávez JAC, Neri Martínez M, Rodríguez A, and Carvajal-Gamez B
- Abstract
Pseudomonas aeruginosa is a pathogen of critical priority importance according to the WHO. Due to its multi-resistance and expression of various virulence factors, it is the causal agent of severe healthcare-acquired infections (HAIs). Effective strategies to control infections caused by P. aeruginosa must include early and specific detection of the pathogen for early and timely antibiotic prescription. The need to develop a specific and reproducible diagnostic technique is urgent, which must often be more sensitive and faster than current clinical diagnostic methods. In this study, we implement and standardize the loop-mediated isothermal amplification (LAMP) technique, coupled with the reverse line blot hybridization (RLBH) technique for the detection of P. aeruginosa . A set of primers and probes was designed to amplify a specific region of the P. aeruginosa 16s rRNA gene. The sensitivity of the LAMP-RLBH method was 3 × 10
-4 ng/μL, 1000 times more sensitive than the PCR and LAMP technique (this work), with a sensitivity of 3 × 10-3 ng/μL. The LAMP-RLBH and LAMP techniques showed specific amplification and no cross-reaction with members of the ESKAPE group and other Pseudomonas species. The present investigation provides a technique that can be easily performed in less time, achieving a faster and more reliable alternative compared to traditional microbial diagnostic methods for the detection of P. aeruginosa .- Published
- 2024
- Full Text
- View/download PDF
37. Differential interactions of Rickettsia species with tick microbiota in Rh. sanguineus and Rh. turanicus.
- Author
-
Maitre A, Kratou M, Corona-Guerrero I, Abuin-Denis L, Mateos-Hernández L, Mosqueda J, Almazan C, Said MB, Piloto-Sardiñas E, Obregon D, and Cabezas-Cruz A
- Subjects
- Animals, Rhipicephalus sanguineus microbiology, Rickettsia Infections microbiology, Rickettsia Infections transmission, Tick-Borne Diseases microbiology, Tick-Borne Diseases transmission, Ticks microbiology, Rickettsia physiology, Microbiota
- Abstract
Tick-borne rickettsioses, caused by Gram-negative bacteria of the Rickettsia genus, pose a growing global threat, with various arthropod vectors contributing to their transmission. Understanding the complex interactions within tick microbiota, including the role of Rickettsia species, is crucial for elucidating the dynamics of rickettsial diseases. Here, we investigate the taxonomic profiles and co-occurrence networks of Rickettsia in Rh. sanguineus sensus lato (s.l.) and Rh. turanicus ticks, revealing significant differences in community composition and local connectivity of Rickettsia species. While the microbiota of both tick species share common taxa, distinct differences in relative abundance and network topology suggest unique ecological niches. Moreover, robustness analysis demonstrates varying resilience to perturbations, indicating different strategies for network organization. Our findings also highlight metabolic differences between tick species, suggesting potential implications for Rickettsia interactions. Overall, this study provides insights into the intricate microbial landscape within ticks, shedding light on the functional redundancy and metabolic pathways associated with Rickettsia, thus advancing our understanding of tick-borne diseases., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
38. Disruption of bacterial interactions and community assembly in Babesia-infected Haemaphysalis longicornis following antibiotic treatment.
- Author
-
Kratou M, Maitre A, Abuin-Denis L, Piloto-Sardiñas E, Corona-Guerrero I, Cano-Argüelles AL, Wu-Chuang A, Bamgbose T, Almazan C, Mosqueda J, Obregón D, Mateos-Hernández L, Said MB, and Cabezas-Cruz A
- Subjects
- Animals, Babesia drug effects, Babesia genetics, Microbial Interactions drug effects, Babesiosis parasitology, Babesiosis transmission, Babesiosis drug therapy, Babesia microti drug effects, Babesia microti genetics, Haemaphysalis longicornis, Anti-Bacterial Agents pharmacology, Ixodidae microbiology, Ixodidae drug effects, Ixodidae parasitology, Microbiota drug effects, Bacteria drug effects, Bacteria genetics, Bacteria isolation & purification, Bacteria classification
- Abstract
Background: A previous study highlighted the role of antibiotic-induced dysbiosis in the tick microbiota, facilitating the transstadial transmission of Babesia microti from nymph to adult in Haemaphysalis longicornis. This study builds on previous findings by analyzing sequence data from an earlier study to investigate bacterial interactions that could be linked to enhanced transstadial transmission of Babesia in ticks. The study employed antibiotic-treated (AT) and control-treated (CT) Haemaphysalis longicornis ticks to investigate shifts in microbial community assembly. Network analysis techniques were utilized to assess bacterial interactions, comparing network centrality measures between AT and CT groups, alongside studying network robustness and connectivity loss. Additionally, functional profiling was conducted to evaluate metabolic diversity in response to antibiotic treatment., Results: The analysis revealed notable changes in microbial community assembly in response to antibiotic treatment. Antibiotic-treated (AT) ticks displayed a greater number of connected nodes but fewer correlations compared to control-treated (CT) ticks, indicating a less interactive yet more connected microbial community. Network centrality measures such as degree, betweenness, closeness, and eigenvector centrality, differed significantly between AT and CT groups, suggesting alterations in local network dynamics due to antibiotic intervention. Coxiella and Acinetobacter exhibited disrupted connectivity and roles, with the former showing reduced interactions in AT group and the latter displaying a loss of connected nodes, emphasizing their crucial roles in microbial network stability. Robustness tests against node removal showed decreased stability in AT networks, particularly under directed attacks, confirming a susceptibility of the microbial community to disturbances. Functional profile analysis further indicated a higher diversity and richness in metabolic capabilities in the AT group, reflecting potential shifts in microbial metabolism as a consequence of antimicrobial treatment., Conclusions: Our findings support that bacterial interaction traits boosting the transstadial transmission of Babesia could be associated with reduced colonization resistance. The disrupted microbial interactions and decreased network robustness in AT ticks suggest critical vulnerabilities that could be targeted for managing tick-borne diseases., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
39. Immunization of cattle with a Rhipicephalus microplus chitinase peptide containing predicted B-cell epitopes reduces tick biological fitness.
- Author
-
Perez-Soria MME, López-Díaz DG, Jiménez-Ocampo R, Aguilar-Tipacamú G, Ueti MW, and Mosqueda J
- Subjects
- Animals, Cattle, Female, Immunization veterinary, Amino Acid Sequence, Peptides immunology, Genetic Fitness, Chitinases immunology, Chitinases chemistry, Chitinases genetics, Rhipicephalus immunology, Epitopes, B-Lymphocyte immunology, Tick Infestations prevention & control, Tick Infestations veterinary, Tick Infestations parasitology, Cattle Diseases prevention & control, Cattle Diseases parasitology, Cattle Diseases immunology, Vaccines immunology
- Abstract
Rhipicephalus microplus , the cattle fever tick, is the most important ectoparasite impacting the livestock industry worldwide. Overreliance on chemical treatments for tick control has led to the emergence of acaricide-resistant ticks and environmental contamination. An immunological strategy based on vaccines offers an alternative approach to tick control. To develop novel tick vaccines, it is crucial to identify and evaluate antigens capable of generating protection in cattle. Chitinases are enzymes that degrade older chitin at the time of moulting, therefore allowing interstadial metamorphosis. In this study, 1 R. microplus chitinase was identified and its capacity to reduce fitness in ticks fed on immunized cattle was evaluated. First, the predicted amino acid sequence was determined in 4 isolates and their similarity was analysed by bioinformatics. Four peptides containing predicted B-cell epitopes were designed. The immunogenicity of each peptide was assessed by inoculating 2 cattle, 4 times at 21 days intervals, and the antibody response was verified by indirect ELISA. A challenge experiment was conducted with those peptides that were immunogenic. The chitinase gene was successfully amplified and sequenced, enabling comparison with reference strains. Notably, a 99.32% identity and 99.84% similarity were ascertained among the sequences. Furthermore, native protein recognition was demonstrated through western blot assays. Chitinase peptide 3 reduced the weight and oviposition of engorged ticks, as well as larvae viability, exhibiting a 71% efficacy. Therefore, chitinase 3 emerges as a viable vaccine candidate, holding promise for its integration into a multiantigenic vaccine against R. microplus.
- Published
- 2024
- Full Text
- View/download PDF
40. Antiparasitic Evaluation of Aquiluscidin, a Cathelicidin Obtained from Crotalus aquilus , and the Vcn-23 Derivative Peptide against Babesia bovis , B. bigemina and B. ovata .
- Author
-
Hernández-Arvizu EE, Asada M, Kawazu SI, Vega CA, Rodríguez-Torres A, Morales-García R, Pavón-Rocha AJ, León-Ávila G, Rivas-Santiago B, and Mosqueda J
- Abstract
Babesiosis is a growing concern due to the increased prevalence of this infectious disease caused by Babesia protozoan parasites, affecting various animals and humans. With rising worries over medication side effects and emerging drug resistance, there is a notable shift towards researching babesiacidal agents. Antimicrobial peptides, specifically cathelicidins known for their broad-spectrum activity and immunomodulatory functions, have emerged as potential candidates. Aquiluscidin, a cathelicidin from Crotalus aquilus , and its derivative Vcn-23, have been of interest due to their previously observed antibacterial effects and non-hemolytic activity. This work aimed to characterize the effect of these peptides against three Babesia species. Results showed Aquiluscidin's significant antimicrobial effects on Babesia species, reducing the B . bigemina growth rate and exhibiting IC
50 values of 14.48 and 20.70 μM against B . ovata and B . bovis , respectively. However, its efficacy was impacted by serum presence in culture, and it showed no inhibition against a B. bovis strain grown in serum-supplemented medium. Conversely, Vcn-23 did not demonstrate babesiacidal activity. In conclusion, Aquiluscidin shows antibabesia activity in vitro and its efficacy is affected by the presence of serum in the culture medium. Nevertheless, this peptide represents a candidate for further investigation of its antiparasitic properties and provides insights into potential alternatives for the treatment of babesiosis.- Published
- 2024
- Full Text
- View/download PDF
41. Development and validation of a novel detection method for Rickettsia rickettsii using a loop-mediated isothermal amplification assay.
- Author
-
Carvajal-Gamez BI, Olguín-Barrera A, Tinoco-Gracia L, Gordillo-Perez G, Dzul-Rosado K, Aguilar-Tipacamú G, Hidalgo-Ruiz M, and Mosqueda J
- Abstract
Introduction: Rickettsia rickettsii is an obligate, intracellular pathogen and the causative agent of Rocky Mountain spotted fever (RMSF). RMSF is an important zoonotic disease due to its high fatal outcome in humans. The difficulty of clinical diagnosis due to the low sensitivity and specificity of current diagnostic methods are a principal setback. We reported the development of a new method for the detection of R. rickettsii in human and tick DNA samples using loop-mediated isothermal amplification (LAMP), as well as the validation of the LAMP test for R. rickettsii in field samples of infected ticks and humans, determining the diagnostic sensitivity and specificity, as well as the reproducibility of the test., Methods: This technique uses hydroxy naphthol blue (HNB) as an indicator of the formation of magnesium pyrophosphate, a marker for the presence of DNA. Here, we used a putative R. rickettsii gene as a target for three pairs of primers that specifically amplify R. rickettsii DNA by hairpin-based isothermal amplification technique (LAMP)., Results and Discussion: The sensitivity of the assay was ~1.6-3 pg, which is 10 times more sensitive than PCR. To determine the diagnostics specificity and sensitivity, 103 human DNA samples and 30 tick DNA samples were evaluated. For the human samples, a sensitivity for HNB of 93%, a specificity of 70% and a k of 0.53 were obtained. For electrophoresis the sensitivity was 97% with a specificity of 58% and a k of 0.42. For tick samples, a sensitivity of 80% was obtained, a specificity of 93% for HNB and for electrophoresis the sensitivity and specificity were 87%. The k for both was 0.73. The degree of concordance between HNB and electrophoresis was 0.82 for humans and for ticks, it was 0.87. The result is obtained in shorter time, compared to a PCR protocol, and is visually interpreted by the color change. Therefore, this method could be a reliable tool for the early diagnosis of rickettsiosis., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Carvajal-Gamez, Olguín-Barrera, Tinoco-Gracia, Gordillo-Perez, Dzul-Rosado, Aguilar-Tipacamú, Hidalgo-Ruiz and Mosqueda.)
- Published
- 2024
- Full Text
- View/download PDF
42. Evaluation of the humoral and mucosal immune response of a multiepitope vaccine against COVID-19 in pigs.
- Author
-
Mosqueda J, Hernández-Silva DJ, Vega-López MA, Vega-Rojas LJ, Beltrán R, Velasco-Elizondo A, Ramírez-Estudillo MDC, Fragoso-Saavedra M, Pérez-Almeida C, Hernández J, Melgoza-González EA, Hinojosa-Trujillo D, Mercado-Uriostegui MÁ, Mejía-López AS, Rivera-Ballesteros C, and García-Gasca T
- Subjects
- Swine, Animals, Humans, Immunity, Mucosal, COVID-19 Vaccines, SARS-CoV-2, Angiotensin-Converting Enzyme 2, Swine, Miniature, Epitopes, T-Lymphocyte, Immunoglobulin A, Immunoglobulin G, COVID-19 prevention & control, Vaccines
- Abstract
Introduction: This study evaluated the immune response to a multiepitope recombinant chimeric protein (CHIVAX) containing B- and T-cell epitopes of the SARS-CoV-2 spike's receptor binding domain (RBD) in a translational porcine model for pre-clinical studies., Methods: We generated a multiepitope recombinant protein engineered to include six coding conserved epitopes from the RBD domain of the SARS-CoV-2 S protein. Pigs were divided into groups and immunized with different doses of the protein, with serum samples collected over time to determine antibody responses by indirect ELISA and antibody titration. Peptide recognition was also analyzed by Western blotting. A surrogate neutralization assay with recombinant ACE2 and RBDs was performed. Intranasal doses of the immunogen were also prepared and tested on Vietnamese minipigs., Results: When the immunogen was administered subcutaneously, it induced specific IgG antibodies in pigs, and higher doses correlated with higher antibody levels. Antibodies from immunized pigs recognized individual peptides in the multiepitope vaccine and inhibited RBD-ACE2 binding for five variants of concern (VOC). Comparative antigen delivery methods showed that both, subcutaneous and combined subcutaneous/intranasal approaches, induced specific IgG and IgA antibodies, with the subcutaneous approach having superior neutralizing activity. CHIVAX elicited systemic immunity, evidenced by specific IgG antibodies in the serum, and local mucosal immunity, indicated by IgA antibodies in saliva, nasal, and bronchoalveolar lavage secretions. Importantly, these antibodies demonstrated neutralizing activity against SARS-CoV-2 in vitro ., Discussion: The elicited antibodies recognized individual epitopes on the chimeric protein and demonstrated the capacity to block RBD-ACE2 binding of the ancestral SARS-CoV-2 strain and four VOCs. The findings provide proof of concept for using multiepitope recombinant antigens and a combined immunization protocol to induce a neutralizing immune response against SARS-CoV-2 in the pig translational model for preclinical studies., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Mosqueda, Hernández-Silva, Vega-López, Vega-Rojas, Beltrán, Velasco-Elizondo, Ramírez-Estudillo, Fragoso-Saavedra, Pérez-Almeida, Hernández, Melgoza-González, Hinojosa-Trujillo, Mercado-Uriostegui, Mejía-López, Rivera-Ballesteros and García-Gasca.)
- Published
- 2023
- Full Text
- View/download PDF
43. Aquiluscidin, a Cathelicidin from Crotalus aquilus , and the Vcn-23 Derivative Peptide, Have Anti-Microbial Activity against Gram-Negative and Gram-Positive Bacteria.
- Author
-
Hernández-Arvizu EE, Silis-Moreno TM, García-Arredondo JA, Rodríguez-Torres A, Cervantes-Chávez JA, and Mosqueda J
- Abstract
Anti-microbial peptides play a vital role in the defense mechanisms of various organisms performing functions that range from the elimination of microorganisms, through diverse mechanisms, to the modulation of the immune response, providing protection to the host. Among these peptides, cathelicidins, a well-studied family of anti-microbial peptides, are found in various animal species, including reptiles. Due to the rise in anti-microbial resistance, these compounds have been suggested as potential candidates for developing new drugs. In this study, we identified and characterized a cathelicidin-like peptide called Aquiluscidin (Aq-CATH) from transcripts obtained from the skin and oral mucosa of the Querétaro's dark rattlesnake, Crotalus aquilus . The cDNA was cloned, sequenced, and yielded a 566-base-pair sequence. Using bioinformatics, we predicted that the peptide precursor contains a signal peptide, a 101-amino-acid conserved cathelin domain, an anionic region, and a 34-amino-acid mature peptide in the C-terminal region. Aq-CATH and a derived 23-amino-acid peptide (Vcn-23) were synthesized, and their anti-microbial activity was evaluated against various species of bacteria in in vitro assays. The minimal inhibitory concentrations against bacteria ranged from 2 to 8 μg/mL for both peptides. Furthermore, at concentrations of up to 50 μM, they exhibited no significant hemolytic activity (<2.3% and <1.2% for Aquiluscidin and Vcn-23, respectively) against rat erythrocytes and displayed no significant cytotoxic activity at low concentrations (>65% cell viability at 25 µM). Finally, this study represents the first identification of an antimicrobial peptide in Crotalus aquilus , which belongs to the cathelicidin family and exhibits the characteristic features of these peptides. Both Aq-CATH and its derived molecule, Vcn-23, displayed remarkable inhibitory activity against all tested bacteria, highlighting their potential as promising candidates for further antimicrobial research.
- Published
- 2023
- Full Text
- View/download PDF
44. Low Genetic Diversity of the Only Clade of the Tick Rhipicephalus microplus in the Neotropics.
- Author
-
Díaz-Sánchez S, Hernández-Triana LM, Labruna MB, Merino O, Mosqueda J, Nava S, Szabó M, Tarragona E, Venzal JM, de la Fuente J, and Estrada-Peña A
- Abstract
This study addresses the variability of the mitochondrial cytochrome oxidase subunit I ( COI ) and 16S rDNA ( 16S ), and nuclear internal transcriber spacer ITS2 ( ITS2 ) genes in a set of field-collected samples of the cattle tick, Rhipicephalus microplus (Canestrini, 1888), and in geo-referenced sequences obtained from GenBank. Since the tick is currently considered to be a complex of cryptic taxa in several regions of the world, the main aims of the study are (i) to provide evidence of the clades of the tick present in the Neotropics, (ii) to explore if there is an effect of climate traits on the divergence rates of the target genes, and (iii) to check for a relationship between geographical and genetic distance among populations (the closest, the most similar, meaning for slow spread). We included published sequences of Rhipicephalus annulatus (Nearctic, Afrotropical, and Mediterranean) and R. microplus (Afrotropical, Indomalayan) to fully characterize the Neotropical populations (total: 74 16S , 44 COI , and 49 ITS2 sequences included in the analysis). Only the clade A of R. microplus spread in the Nearctic-Neotropics. Both the K and Lambda's statistics, two measures of phylogenetic signal, support low divergence rates of the tested genes in populations of R. microplus in the Neotropics. These tests demonstrate that genetic diversity of the continental populations does not correlate either with the geographic distance among samples or with environmental variables. The low variability of these genes may be due to a combination of factors like (i) the recent introduction of the tick in the Neotropics, (ii) a large, effective, and fast exchange of populations, and (iii) a low effect of climate on the evolution rates of the target genes. These results have implications for the ecological studies and control of cattle tick infestations.
- Published
- 2023
- Full Text
- View/download PDF
45. Morphological and molecular identification of the brown dog tick in Mexico.
- Author
-
Almazán C, Reyes de Luna G, Tinoco-Gracia L, González-Álvarez VH, Zając Z, Kulisz J, Woźniak A, Cabezas-Cruz A, and Mosqueda J
- Subjects
- Dogs, Animals, Mexico, Climate, DNA, Ribosomal, Ehrlichia canis, Rhipicephalus sanguineus
- Abstract
Ticks of the Rhipicephalus sanguineus complex are known as the brown dog ticks. This complex groups at least 12 species of ticks that are distributed worldwide. On the American continents, R. sanguineus sensu stricto (s.s.), is distributed in temperate areas, while Rhipicephalus sanguineus sensu lato (s.l.), also called "tropical lineage" is distributed in tropical regions. Previous analyses of brown dog ticks from Mexico have identified the so-called tropical lineage and the country generally has a climate more favorable for these ticks (> 20
o C in average). In addition, some pathogens thought to be transmitted by this lineage (such as Ehrlichia canis, and Rickettsia rickettsii) are prevalent in Mexico. Herein we aim to contribute to the study of brown dog ticks by providing morphological identification and molecular analysis of mt 12S rDNA and 16S rDNA sequences from ticks collected from 12 states in Mexico. Our results indicate that the tropical lineage of R. sanguineus s.l., recently redescribed as R. linnaei is widely distributed in Mexico., Competing Interests: Declaration of Competing Interest The authors declare no conflict of interest., (Copyright © 2023 Elsevier B.V. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
46. Identification and Characterization of Rhipicephalus microplus ATAQ Homolog from Haemaphysalis longicornis Ticks and Its Immunogenic Potential as an Anti-Tick Vaccine Candidate Molecule.
- Author
-
Adjou Moumouni PF, Naomasa S, Tuvshintulga B, Sato N, Okado K, Zheng W, Lee SH, Mosqueda J, Suzuki H, Xuan X, and Umemiya-Shirafuji R
- Abstract
Although vaccines are one of the environmentally friendly means to prevent the spread of ticks, there is currently no commercial vaccine effective against Haemaphysalis longicornis ticks. In this study, we identified, characterized, localized, and evaluated the expression patterns, and tested the immunogenic potential of a homologue of Rhipicephalus microplus ATAQ in H. longicornis (HlATAQ). HlATAQ was identified as a 654 amino acid-long protein present throughout the midgut and in Malpighian tubule cells and containing six full and one partial EGF-like domains. HlATAQ was genetically distant (homology < 50%) from previously reported ATAQ proteins and was expressed throughout tick life stages. Its expression steadily increased ( p < 0.001) during feeding, reached a peak, and then decreased slightly with engorgement. Silencing of HlATAQ did not result in a phenotype that was significantly different from the control ticks. However, H. longicornis female ticks fed on a rabbit immunized with recombinant HlATAQ showed significantly longer blood-feeding periods, higher body weight at engorgement, higher egg mass, and longer pre-oviposition and egg hatching periods than control ticks. These findings indicate that the ATAQ protein plays a role in the blood-feeding-related physiological processes in the midgut and Malpighian tubules and antibodies directed against it may affect these tissues and disrupt tick engorgement and oviposition.
- Published
- 2023
- Full Text
- View/download PDF
47. Spherical Body Protein 4 from Babesia bigemina : A Novel Gene That Contains Conserved B-Cell Epitopes and Induces Cross-Reactive Neutralizing Antibodies in Babesia ovata .
- Author
-
Mosqueda J, Hernandez-Silva DJ, Ueti MW, Cruz-Reséndiz A, Marquez-Cervantez R, Valdez-Espinoza UM, Dang-Trinh MA, Nguyen TT, Camacho-Nuez M, Mercado-Uriostegui MA, Aguilar-Tipacamú G, Ramos-Aragon JA, Hernandez-Ortiz R, Kawazu SI, and Igarashi I
- Abstract
Bovine babesiosis is a tick-transmitted disease caused by intraerythrocytic protozoan parasites of the genus Babesia . Its main causative agents in the Americas are Babesia bigemina and Babesia bovis, while Babesia ovata affects cattle in Asia. All Babesia species secrete proteins stored in organelles of the apical complex, which are involved in all steps of the invasion process of vertebrate host cells. Unlike other apicomplexans, which have dense granules, babesia parasites instead have large, round intracellular organelles called spherical bodies. Evidence suggests that proteins from these organelles are released during the process of invading red blood cells, where spherical body proteins (SBPs) play an important role in cytoskeleton reorganization. In this study, we characterized the gene that encodes SBP4 in B. bigemina . This gene is transcribed and expressed in the erythrocytic stages of B. bigemina . The sbp4 gene consists of 834 nucleotides without introns that encode a protein of 277 amino acids. In silico analysis predicted a signal peptide that is cleaved at residue 20, producing a 28.88-kDa protein. The presence of a signal peptide and the absence of transmembrane domains suggest that this protein is secreted. Importantly, when cattle were immunized with recombinant B. bigemina SBP4, antibodies identified B. bigemina and B. ovata merozoites according to confocal microscopy observations and were able to neutralize parasite multiplication in vitro for both species. Four peptides with predicted B-cell epitopes were identified to be conserved in 17 different isolates from six countries. Compared with the pre-immunization sera, antibodies against these conserved peptides reduced parasite invasion in vitro by 57%, 44%, 42%, and 38% for peptides 1, 2, 3, and 4, respectively ( p < 0.05). Moreover, sera from cattle infected with B. bigemina cattle contained antibodies that recognized the individual peptides. All these results support the concept of spb4 as a new gene in B. bigemina that should be considered a candidate for a vaccine to control bovine babesiosis.
- Published
- 2023
- Full Text
- View/download PDF
48. A20 binding and inhibitor of nuclear factor kappa B (NF-κB)-1 (ABIN-1): a novel modulator of mitochondrial autophagy.
- Author
-
Merline R, Rödig H, Zeng-Brouwers J, Poluzzi C, Tascher G, Michaelis J, Lopez-Mosqueda J, Rhiner A, Huber LS, Diehl V, Dikic I, Kögel D, Münch C, Wygrecka M, and Schaefer L
- Subjects
- Humans, HeLa Cells, Protein Binding, Autophagy, Ubiquitin-Protein Ligases metabolism, NF-kappa B metabolism, Mitochondria metabolism
- Abstract
A20 binding inhibitor of nuclear factor kappa B (NF-κB)-1 (ABIN-1), a polyubiquitin-binding protein, is a signal-induced autophagy receptor that attenuates NF-κB-mediated inflammation and cell death. The present study aimed to elucidate the potential role of ABIN-1 in mitophagy, a biological process whose outcome is decisive in diverse physiological and pathological settings. Microtubule-associated proteins 1A/1B light chain 3B-II (LC3B-II) was found to be in complex with ectopically expressed hemagglutinin (HA)-tagged-full length (FL)-ABIN-1. Bacterial expression of ABIN-1 and LC3A and LC3B showed direct binding of ABIN-1 to LC3 proteins, whereas mutations in the LC3-interacting region (LIR) 1 and 2 motifs of ABIN-1 abrogated ABIN-1/LC3B-II complex formation. Importantly, induction of autophagy in HeLa cells resulted in colocalization of ABIN-1 with LC3B-II in autophagosomes and with lysosomal-associated membrane protein 1 (LAMP-1) in autophagolysosomes, leading to degradation of ABIN-1 with p62. Interestingly, ABIN-1 was found to translocate to damaged mitochondria in HeLa-mCherry-Parkin transfected cells. In line with this observation, clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9)-mediated deletion of ABIN-1 significantly inhibited the degradation of the mitochondrial outer membrane proteins voltage-dependent anion-selective channel 1 (VDAC-1), mitofusin-2 (MFN2), and translocase of outer mitochondrial membrane (TOM)20. In addition, short interfering RNA (siRNA)-mediated knockdown of ABIN-1 significantly decreased lysosomal uptake of mitochondria in HeLa cells expressing mCherry-Parkin and the fluorescence reporter mt-mKEIMA. Collectively, our results identify ABIN-1 as a novel and selective mitochondrial autophagy regulator that promotes mitophagy, thereby adding a new player to the complex cellular machinery regulating mitochondrial homeostasis.
- Published
- 2023
- Full Text
- View/download PDF
49. Rickettsia Vaccine Candidate pVAX1-OmpB24 Stimulates TCD4+INF-γ+ and TCD8+INF-γ+ Lymphocytes in Autologous Co-Culture of Human Cells.
- Author
-
Dzul-Rosado K, Donis-Maturano L, Arias-León J, Machado-Contreras J, Valencia-Pacheco G, Panti-Balam C, Balam-Romero J, Ku-González A, Peniche-Lara G, Mosqueda J, Zazueta OE, Lugo-Caballero C, and Puerto-Manzano F
- Abstract
Background: In recent years, promising vaccination strategies against rickettsiosis have been described in experimental animal models and human cells. OmpB is considered an immunodominant antigen that is recognized by T and B cells. The aim of this study was to identify TCD4+INF-γ+ and TCD8+INF-γ+ lymphocytes in an autologous system with macrophages transfected with the vaccine candidate pVAX1-OmpB24. Lymphocytes and monocytes from 14 patients with Rickettsia were isolated from whole blood. Monocytes were differentiated into macrophages and transfected with the plasmid pVAX1-OmpB24 pVax1. Isolated lymphocytes were cultured with transfected macrophages. IFN-γ-producing TCD4+ and TCD8+ lymphocyte subpopulations were identified by flow cytometry, as was the percentage of macrophages expressing CD40+, CD80+, HLA-I and HLA-II. Also, we analyzed the exhausted condition of the T lymphocyte subpopulation by PD1 expression. Macrophages transfected with pVAX1-OmpB24 stimulated TCD4+INF-γ+ cells in healthy subjects and patients infected with R. typhi . Macrophages stimulated TCD8+INF-γ+ cells in healthy subjects and patients infected with R. rickettsii and R. felis . Cells from healthy donors stimulated with OmpB-24 showed a higher percentage of TCD4+PD1+. Cells from patients infected with R. rickettsii had a higher percentage of TCD8+PD-1+, and for those infected with R. typhi the larger number of cells corresponded to TCD4+PD1+. Human macrophages transfected with pVAX1-OmpB24 activated TCD4+IFN-γ+ and CD8+IFN-γ+ in patients infected with different Rickettsia species. However, PD1 expression played an important role in the inhibition of T lymphocytes with R. felis.
- Published
- 2023
- Full Text
- View/download PDF
50. Development and standardization of a Loop-mediated isothermal amplification (LAMP) test for the detection of Babesia bigemina .
- Author
-
Lizarazo-Zuluaga AP, Carvajal-Gamez BI, Wilkowsky S, Cravero S, Trangoni M, and Mosqueda J
- Abstract
Bovine babesiosis is a tick-borne disease caused by protozoan parasites of the genus Babesia . Babesia bigemina is one of the most prevalent and economically important parasite species that infects cattle because of its impact on the meat and milk production industry. Effective disease control strategies should include detection of reservoir animals and early and specific pathogen detection using rapid, economical, sensitive, and specific detection techniques. The loop-mediated isothermal amplification technique (LAMP) is a one-step molecular reaction that amplifies DNA sequences with high sensitivity and specificity under isothermal conditions and requires no special equipment. The results can be observed by the naked eye as color changes. The aim of this work was to develop and standardize the LAMP technique for B. bigemina detection and its visualization using hydroxynaphtol blue. For this situation, primers were designed from the conserved sequences of the B. bigemina ama-1 gene. The results showed that at 63 °C in 1 h and under standardized conditions, this technique could amplify B. bigemina DNA as indicated by the characteristic colorimetric change. Sensitivity evaluation indicated that DNA was amplified at a 0.00000001% parasitemia, and it was demonstrated that this technique specifically amplified the DNA of B. bigemina . Additionally, this technique could amplify DNA from 10 strains of B. bigemina from three different countries. It is concluded that the LAMP technique as modified in our case could specifically amplify B. bigemina DNA and shows high sensitivity, does not cross-react with related organisms, and the product is observed by 60 min of reaction time based on color changes. This report is the first LAMP report that uses sequences that are conserved between strains of the ama-1 gene, demonstrates the results by color changes using hydroxynaphtol blue. We propose LAMP as a rapid and economical alternative method for the molecular detection of B. bigemina ., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Lizarazo-Zuluaga, Carvajal-Gamez, Wilkowsky, Cravero, Trangoni and Mosqueda.)
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.